Combination treatment with lamivudine plus interleukin-12 shows greater antiviral activity in chronic hepatitis B.

被引:0
|
作者
Naoumov, NV
Suri, D
Rigopoulou, EI
Machell, T
Mullerova, I
Chokshi, S
Rice, S
Tedder, RS
Williams, R
机构
[1] UCL, Inst Hepatol, London, England
[2] UCL, Dept Virol, London, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
868
引用
收藏
页码:376A / 376A
页数:1
相关论文
共 50 条
  • [31] Pegylated interferon has additional antiviral effect on lamivudine in the treatment of chronic hepatitis B
    Chan, HL
    Wong, ML
    Leung, NW
    Hui, AY
    Hung, LC
    Chan, FK
    Sung, JJ
    HEPATOLOGY, 2002, 36 (04) : 624A - 624A
  • [32] How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?
    Jurriën GP Reijnders
    Harry LA Janssen
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 668 - 669
  • [33] How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?
    Reijnders, Jurrien G. P.
    Janssen, Harry L. A.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (12): : 668 - 669
  • [34] Immunomodulation with interleukin-12 improves the efficacy of therapeutic vaccine in patients with chronic hepatitis B
    Loehr, H
    Bubl, B
    Boecher, W
    Herzog-Hauff, S
    Hoffstedt, M
    Galle, P
    JOURNAL OF HEPATOLOGY, 2002, 36 : 224 - 224
  • [35] Combination of pegylated interferon and lamivudine is superior to lamivudine monotherapy in the treatment of chronic hepatitis B - A randomized trial
    Sung, JJY
    Chan, HLY
    Hui, A
    Chan, FKL
    Chim, AML
    Wong, ML
    Leung, NWY
    JOURNAL OF HEPATOLOGY, 2003, 38 : 33 - 33
  • [36] Coadministration of hills vaccine plus interleukin-12 induced T cell responses and viral clearance in patients with chronic hepatitis B
    Loehr, H
    Bubl, B
    Boecher, W
    Herzog-Hauff, S
    Galle, P
    GASTROENTEROLOGY, 2002, 123 (01) : 67 - 67
  • [37] Adefovir dipivoxil plus lamivudine combination treatment is superior to adefovir dipivoxil monotherapy in lamivudine-resistant hepatitis B E antigen-negative chronic hepatitis B patients
    Vassiliadis, Themistoklis
    Giouleme, Olga
    Koumerkeridis, Georgios
    Charalompos, Koumaras
    Tziomalos, Konstantinos
    Patsiaoura, Koliopi
    Mpoumponaris, Alexander
    Gkisakis, Dimitrios
    Theodoropoulos, Konstantinos
    Grammatikos, Nikolaos
    Panderi, Athanasia
    Nikolaidis, Nikolaos
    Evgenidis, Nikolaos
    HEPATOLOGY, 2007, 46 (04) : 662A - 663A
  • [38] Combination of peginterferon alfa-2b and lamivudine is superior to lamivudine alone in the treatment of chronic hepatitis B infection
    Sung, JJY
    Chan, HLY
    Hui, AY
    Wong, VWS
    Liew, CT
    Chim, AML
    Chan, FKL
    Hung, LCT
    Lee, YT
    Leung, NWY
    GASTROENTEROLOGY, 2004, 126 (04) : A682 - A682
  • [39] Comparison of 6 versus 12 months Hepatitis B immume globulin in combination with lamivudine as prophylaxis in liver transplant recipients with Hepatitis B.
    Kim, DD
    Heffernan, DJ
    Bass, NM
    Roberts, JP
    Ascher, NL
    Terrault, NA
    HEPATOLOGY, 2002, 36 (04) : 221A - 221A
  • [40] Lamivudine and lamivudine plus interferon treatment in naive anti-HBe positive patients with chronic hepatitis B
    Akarca, US
    Ersoz, G
    Gunsar, F
    Kilicsoy, N
    Karasu, Z
    Vardar, R
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2001, 34 : 164 - 164